CClinicalTrials.gg
CompletedNCT07095816Updated Jul 31, 2025

Acetaminophen Before Surgery Lowers Postop Pain in Pediatric Solid Tumor Patients (ERAS)

A Phase 1 interventional study of Acetaminophen and Sterilized water in Analgesic, Enhanced Recovery After Surgery and Postoperative Pain, sponsored by Nanjing Children's Hospital. Completed at 1 site in China. Open to participants aged 1 Month to 15 Years. Per ClinicalTrials.gov, last updated 2025-07-31.

Sponsored by Nanjing Children's Hospital · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
182
Allocation
Randomized
Ages
1 Month to 15 Years
Sex
All
01

Study summary

Pain is the predominant subjective symptom experienced during the perioperative period in pediatric patients with solid tumors. Intense pain may impede early postoperative activities and delay the recovery process. Preemptive analgesia,as a component of multimodal analgesia strategies,aims to mitigate pain by administering analgesic interventions prior to the application of a noxious stimulus. This approach seeks to diminish both peripheral and central sensitization to pain,thereby alleviating postoperative pain. Currently,while preoperative acetaminophen is widely used in adult surgeries,research is limited for its use in pediatrics. This study aims to evaluate the impact of preemptive acetaminophen on reducing postoperative pain in children with solid tumors under the mode of ERAS.

Read the detailed description

Pediatric oncology patients face unique challenges due to their distinct clinical profile. Solid tumors like neuroblastomas, teratomas, and rhabdomyosarcomas often develop in complex areas such as the retroperitoneum, pelvis, or mediastinum, where they grow invasively and can encase major blood vessels. Children typically have larger tumor-to-body size ratios than adults, necessitating more extensive surgeries and resulting in larger wounds from tumor and lymph node removal. Their poor preoperative nutrition and compromised healing abilities, due to both their disease and treatments, lead to slower wound healing and higher risk of complications.

Managing pain in pediatric cancer patients is challenging. Almost all experience pain, with over 70% facing severe pain, making it their most distressing symptom. Young children's limited cognitive abilities often lead to underreported and undertreated pain, especially after surgery. This unrelieved pain can impair breathing, hinder movement, increase infection risk, and worsen wasting. Most concerning are the potential long-term neurological effects, as significant pain in childhood may lead to lasting changes in brain structure and function.

A comprehensive meta-analysis highlights several effective preemptive analgesics, including lornoxicam, pregabalin, ibuprofen, gabapentin, and acetaminophen (APAP). APAP is particularly popular in pediatrics for its safety when properly dosed. It is quickly absorbed in the gut and metabolized in the liver, primarily by cytochrome P450 enzymes, producing a toxic intermediate, NAPQI, which is detoxified by glutathione. APAP's analgesic effects involve peripheral COX inhibition and central modulation of COX, serotonin, L-arginine/NO, endocannabinoid, and redox pathways. Preoperative APAP can prevent pain sensitization by blocking nociceptive signal transmission to the central nervous system.

APAP has proven effective for preemptive analgesia in pediatric surgeries like tonsillectomy and appendectomy, reducing pain and enhancing recovery. However, its role in pediatric oncologic surgery is unstudied, highlighting a need to explore its use in ERAS protocols for pain management in tumor resections. This study seeks to fill that gap, potentially improving perioperative pain care for these patients.

02

Conditions studied

  • Analgesic
  • Enhanced Recovery After Surgery
  • Postoperative Pain
  • Acetaminophen
  • Tumor
03

Who can participate

Ages eligible
1 Month to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Informed Consent: Written informed consent was obtained from the parents or legal guardians of all pediatric participants.

    • Age Requirement: Patients aged >1 month (infants and children) were eligible for enrollment.

      • Diagnosis \& Treatment:

        • Radiologically or pathologically confirmed solid tumors. Ⅱ.Scheduled to undergo tumor resection surgery in the Department of Pediatric Surgical Oncology, Children's Hospital Affiliated to Nanjing Medical University.

Exclusion criteria

Exclusion Criteria:

  • Lack of Informed Consent: Parental/guardian informed consent was not obtained. ②Allergy/Intolerance: Known hypersensitivity or contraindication to acetaminophen (paracetamol).

    • Hepatic Impairment:Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels >3× the upper limit of normal (ULN).

      • Renal Dysfunction:Serum urea or creatinine levels exceeding the ULN. ⑤Recent Analgesic Use: Administration of any analgesic medication within 12 hours preoperatively.

        • PCA Exclusion: Patients not receiving postoperative intravenous patient-controlled analgesia (PCA).
04

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
182 participants (actual)

Study arms

  • Experimental
    Acetaminophen(APAP)

    The experimental group received oral acetaminophen(10 mg/kg)two hours prior to surgery.

    Drug: Acetaminophen

  • Placebo comparator
    sterilized water

    The placebo group received 10 mg/kg sterilized water two hours prior to surgery.

    Drug: Sterilized water

Interventions

  • DrugAcetaminophen

    A prospective randomized controlled trial was conducted involving pediatric patients with solid tumors. Participants who met the inclusion criteria were randomly assigned using a computer-generated random number table. The APAP group was administered acetaminophen orally at a dose of 10 mg/kg body weight 2 hours before the surgical procedure.

  • DrugSterilized water

    The placebo group was administered 10 mg/kg of sterile water orally two hours before the surgical procedure.

05

What researchers measure

Primary outcomes

  1. Using FLACC scale to assess the pain level at 1 hour after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 1 hour after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 1 hour after postoperative awakening

  2. Using FLACC scale to assess the pain level at 3 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 3 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 3 hours after postoperative awakening

  3. Using FLACC scale to assess the pain level at 6 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 6 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 6 hours after postoperative awakening

  4. Using FLACC scale to assess the pain level at 12 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 12 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 12 hours after postoperative awakening

  5. Using FLACC scale to assess the pain level at 24 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 24 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 24 hours after postoperative awakening

  6. Using FLACC scale to assess the pain level at 48 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 48 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 48 hours after postoperative awakening

  7. Using NRS scale to assess the pain level at 1 hour after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 1 hour after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 1 hour after postoperative awakening

  8. Using NRS scale to assess the pain level at 3 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 3 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 3 hours after postoperative awakening

  9. Using NRS scale to assess the pain level at 6 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 6 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 6 hours after postoperative awakening

  10. Using NRS scale to assess the pain level at 12 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 12 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 12 hours after postoperative awakening

  11. Using NRS scale to assess the pain level at 24 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 24 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 24 hours after postoperative awakening

  12. Using NRS scale to assess the pain level at 48 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 48 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    Time frame: 48 hours after postoperative awakening

Secondary outcomes

  1. The number of patient-controlled analgesia (PCA) pump activations

    The number of patient-controlled analgesia (PCA) pump activations within 48 hours postoperatively

    Time frame: during the first 48 postoperative hours

  2. Serum Alanine Aminotransferase (ALT) Concentration

    alanine aminotransferase

    Time frame: 24 hours after surgery

  3. Serum Aspartate Aminotransferase (AST) Concentration

    aspartate aminotransferase

    Time frame: 24 hours after surgery

  4. Serum Urea Concentration

    urea

    Time frame: 24 hours after surgery

  5. Plasma Creatinine Concentration

    creatinine values

    Time frame: 24 hours after surgery

  6. Serum Procalcitonin Concentration (ng/mL)

    Postoperative inflammatory markers including procalcitonin, C-reactive protein, white blood cell count, absolute neutrophil count, absolute lymphocyte count, and neutrophil-to-lymphocyte ratio.

    Time frame: 24 hours after surgery

  7. Serum C-Reactive Protein Concentration (mg/L)

    Postoperative inflammatory markers including procalcitonin, C-reactive protein, white blood cell count, absolute neutrophil count, absolute lymphocyte count, and neutrophil-to-lymphocyte ratio.

    Time frame: 24 hours after surgery

  8. Peripheral White Blood Cell Count (×10⁹/L)

    Postoperative inflammatory markers including procalcitonin, C-reactive protein, white blood cell count, absolute neutrophil count, absolute lymphocyte count, and neutrophil-to-lymphocyte ratio.

    Time frame: 24 hours after surgery

  9. Absolute Neutrophil Count (×10⁹/L)

    Postoperative inflammatory markers including procalcitonin, C-reactive protein, white blood cell count, absolute neutrophil count, absolute lymphocyte count, and neutrophil-to-lymphocyte ratio.

    Time frame: 24 hours after surgery

  10. Absolute Lymphocyte Count (×10⁹/L)

    Postoperative inflammatory markers including procalcitonin, C-reactive protein, white blood cell count, absolute neutrophil count, absolute lymphocyte count, and neutrophil-to-lymphocyte ratio.

    Time frame: 24 hours after surgery

  11. Neutrophil-to-Lymphocyte Ratio

    Postoperative inflammatory markers including procalcitonin, C-reactive protein, white blood cell count, absolute neutrophil count, absolute lymphocyte count, and neutrophil-to-lymphocyte ratio.

    Time frame: 24 hours after surgery

  12. Intraoperative Respiratory Rate (breaths per minute)

    Intraoperative monitoring of respiratory rate, heart rate, systolic blood pressure, and diastolic blood pressure was performed in pediatric patients throughout the surgical procedure.

    Time frame: during the operation

  13. Intraoperative Heart Rate (beats per minute)

    Intraoperative monitoring of respiratory rate, heart rate, systolic blood pressure, and diastolic blood pressure was performed in pediatric patients throughout the surgical procedure.

    Time frame: during the operation

  14. Intraoperative Systolic Blood Pressure (mmHg)

    Intraoperative monitoring of respiratory rate, heart rate, systolic blood pressure, and diastolic blood pressure was performed in pediatric patients throughout the surgical procedure.

    Time frame: during the operation

  15. Intraoperative Diastolic Blood Pressure (mmHg)

    Intraoperative monitoring of respiratory rate, heart rate, systolic blood pressure, and diastolic blood pressure was performed in pediatric patients throughout the surgical procedure.

    Time frame: during the operation

06

Study locations

1 site
  • Children's Hospital of Nanjing Medical University
    Nanjing, Jiangsu 210008, China
07

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (including demographic, clinical, and outcome variables) collected during the trial will be made available to qualified researchers.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07095816
Lead sponsor
Nanjing Children's Hospital
Responsible party
Weibing Tang (Chief of Department of neonatal surgery, Nanjing Children's Hospital) — Principal investigator
First posted
Jul 31, 2025
Start date
May 15, 2023
Primary completion
Feb 27, 2025
Completion
Mar 30, 2025
Last update
Jul 31, 2025

Study contacts

Weibing Tang
study chair · Children's Hospital of Nanjing Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion